In May, India and South Africa called on the World Trade Organization (WTO) to temporarily waive intellectual property (IP) rules related to COVID-19 vaccines, medicines, diagnostics and other technologies.
The draft was co-sponsored by more than 60 countries that had warmed up to the idea. It was initially proposed in October last year amid snail-paced vaccine deliveries during the pandemic as rich countries cornered the bulk of the supplies.
Read more at:
India, South Africa bid to ban COVID vaccine patents finds few takers in Latin America | Business| Economy and finance news from a German perspective | DW | 28.06.2021
